Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MiWEndo

Financiado

Cerrado

REVOLUTIONARY ELECTROMAGNETIC ENDOSCOPY ACCESSORY TO AUTOMATIZE POLYP DETECTION

Every year 1,4 million new cases of colorectal cancer (CRC) are diagnosed. Polyps and early-stage CRCs are usually asymptomatic or have symptoms that can be easily confused with other mild ailments. This cancer can be cured in mor... ver más

31/12/2023

MIWENDO SOLUTIONS

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

MIWENDO SOLUTIONS Desarrollar, fabricar y comercializar soluciones basadas en el uso de las ondas electromagneticas en el rango de las microondas con finalida...

TRL 4-5 | 260K€

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-12-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

MIWENDO SOLUTIONS

1.45M€ | Lider

VANIOS CONSULTING

571.79K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

COLONINFO Improving COLOrectal cancer screening Novel INverse and FOr... 158K€ Cerrado

SUPCAM New cost effective and minimally invasive endoscopic device... 1M€ Cerrado

SMART PILL New optical functions for endoscopic capsules 244K€ Cerrado

PID2021-128602OB-C21 BIOPSIA PULMONAR ELECTRONICA GUIADA POR BRONCOSCOPIA DE NAVE... 103K€ Cerrado

EUIN2015-62783 ENTORNO INALAMBRICO INTRA-CORPORAL PARA LA MEJORA DEL DIAGNO... 22K€ Cerrado

PROSCOPE Point of care instrument for diagnosis and image guided inte... 6M€ Cerrado

Duración del proyecto: 39 meses Fecha Inicio: 2020-09-21
Fecha Fin: 2023-12-31

Líder del proyecto

MIWENDO SOLUTIONS Desarrollar, fabricar y comercializar soluciones basadas en el uso de las ondas electromagneticas en el rango de las microondas con finalida...

TRL 4-5 | 260K€

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Every year 1,4 million new cases of colorectal cancer (CRC) are diagnosed. Polyps and early-stage CRCs are usually asymptomatic or have symptoms that can be easily confused with other mild ailments. This cancer can be cured in more than 90% of cases if precancerous polyps are detected and removed. Colonoscopy is the most effective method to remove polyps in the entire colon. However, 8% of CRCs are diagnosed after a negative colonoscopy, and 22% of polyps are not detected due to visual limitations of the colonoscope camera. MiWEndo Solutions is a medical device startup focused on bringing innovative technologies to practical diagnosis of diseases related with tumor processes. Its first product is MiWEndo, a low cost and safe electromagnetic device designed to be attached to the tip of a conventional colonoscope. MiWEndo automatizes polyp detection emitting an alarm when a polyp is sensed, increases the field of view to 360º and provides quantitative differentiation between malignant and benign polyps without changing current clinical practice. Its core technology is based on microware imaging, and we have developed algorithms that can differentiate between healthy colon mucosa, cancer, and different histological types of polyps based on their dielectric properties. Our technology is protected with European patent EP3195786A1. After CRC detection, additional applications of our technology will include other bowel disorders. We have a financial need of 3,8 M€ between 2020 and 2023 (product launch). Of these, 1,5 M€ will be provided as a grant from the European Commission within the EIC Accelerator Program (2020-2022), corresponding to 70% of the project budget. At the end of the project MiWEndo will have reached TRL8, including a clinical validation in a clinical trial, and will have obtained CE mark and FDA approval prior to product launch in early markets.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores